Virtual cocrystal screening

Calculated gas phase molecular electrostatic potential surfaces have been used to identify sets of H-bond donor and H-bond acceptor sites that describe the possible intermolecular interaction sites on the surface of a molecule. The calculated H-bond parameters, αi and βj, were used to estimate interaction site pairing energies in the solid form of the compound through a hierarchical mapping of complementary donor and acceptor sites: the interaction energy for each contact is simply given by the product −αiβj. The approach assumes that all of the interactions that can be made in the solid are made and that the details of three-dimensional structure and crystal packing are of secondary importance. Comparison of the energy of two pure solids with cocrystals of various stoichiometries gives an energy difference, ΔE, which is a measure of the probability of forming a cocrystal. Tests on an experimental cocrystal screen from the literature and the recall of coformers for caffeine and for carbamazepine from a list of nearly 1,000 candidates have been used to validate the utility of the method. For systems that are experimentally found to form cocrystals, the calculated energy parameter ΔE tends to be very favourable. In the best case, for 846 potential caffeine coformers from the EAFUS list, 80% of the experimentally observed hits are in the top 11% of the ranked list of ΔE values. The results provide a calibration between the value of ΔE and the probability of cocrystal formation: when the cocrystal is favored by more than 11 kJ mol−1 over the two pure solids, the probability of obtaining a cocrystal is better than 50%. An advantage of this approach is that it is sufficiently fast to be used as a high throughput virtual screening tool.

[1]  William Jones,et al.  Recent Advances in Understanding the Mechanism of Cocrystal Formation via Grinding , 2009 .

[2]  M. Berthelot,et al.  Can semi-empirical calculations yield reasonable estimates of hydrogen-bonding basicity? The case of nitriles , 1997 .

[3]  S. Childs,et al.  The role of solvent in mechanochemical and sonochemical cocrystal formation: a solubility-based approach for predicting cocrystallisation outcome , 2009 .

[4]  J. McMahon,et al.  Crystal engineering of the composition of pharmaceutical phases. , 2003, Chemical communications.

[5]  Christer B Aakeröy,et al.  Constructing, deconstructing, and reconstructing ternary supermolecules. , 2007, Chemical communications.

[6]  M. Zaworotko,et al.  Concomitant and Conformational Polymorphism, Conformational Isomorphism, and Phase Relationships in 4-Cyanopyridine·4,4‘-biphenol Cocrystals , 2006 .

[7]  Geoff G. Z. Zhang,et al.  Efficient co-crystal screening using solution-mediated phase transformation. , 2007, Journal of pharmaceutical sciences.

[8]  W. D. Sam Motherwell,et al.  The probable number of hydrogen-bonded contacts for chemical groups in organic crystal structures , 2004 .

[9]  W. Motherwell,et al.  Physical stability enhancement of theophylline via cocrystallization. , 2006, International journal of pharmaceutics.

[10]  Gautam R. Desiraju,et al.  Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities , 2005 .

[11]  Tejender S. Thakur,et al.  Crystal Structure Prediction of a Co-Crystal Using a Supramolecular Synthon Approach: 2-Methylbenzoic Acid−2-Amino-4-methylpyrimidine , 2008 .

[12]  Peddy Vishweshwar,et al.  Pharmaceutical co-crystals. , 2006, Journal of pharmaceutical sciences.

[13]  M. C. Etter,et al.  The use of cocrystallization as a method of studying hydrogen bond preferences of 2-aminopyrimidine , 1990 .

[14]  Richard W. Duerst,et al.  Cocrystals of Caffeine and Hydroxybenzoic Acids Composed of Multiple Supramolecular Heterosynthons: Screening via Solution-Mediated Phase Transformation and Structural Characterization , 2009 .

[15]  T. Friščić,et al.  Screening for inclusion compounds and systematic construction of three-component solids by liquid-assisted grinding. , 2006, Angewandte Chemie.

[16]  Raj Suryanarayanan,et al.  A rapid thermal method for cocrystal screening , 2008 .

[17]  Aeri Park,et al.  Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API , 2006, Pharmaceutical Research.

[18]  Christian Laurence,et al.  Observations on the strength of hydrogen bonding , 2000 .

[19]  William Jones,et al.  Solvent-drop grinding: green polymorph control of cocrystallisation. , 2004, Chemical communications.

[20]  C. Aakeröy,et al.  Supramolecular reagents: versatile tools for non-covalent synthesis. , 2005, Chemical communications.

[21]  Peter T. A. Galek,et al.  Knowledge-based H-bond prediction to aid experimental polymorph screening , 2009 .

[22]  Michael J Cima,et al.  High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids. , 2004, Advanced drug delivery reviews.

[23]  Keith Chadwick,et al.  How does grinding produce co-crystals? Insights from the case of benzophenone and diphenylamine , 2007 .

[24]  J. G. Vinter,et al.  Solvent effects on hydrogen bonding. , 2007, Angewandte Chemie.

[25]  R. Davey,et al.  Making Co-crystals-The utility of ternary phase diagrams , 2007 .

[26]  P. Karamertzanis,et al.  Can the Formation of Pharmaceutical Cocrystals Be Computationally Predicted? I. Comparison of Lattice Energies , 2009 .

[27]  Michael J. Zaworotko,et al.  Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? , 2004 .

[28]  Alan R. Kennedy,et al.  Targeted crystallisation of novel carbamazepine solvates based on a retrospective Random Forest classification , 2008 .

[29]  K. Arora,et al.  Hierarchy of Supramolecular Synthons: Persistent Carboxylic Acid···Pyridine Hydrogen Bonds in Cocrystals That also Contain a Hydroxyl Moiety , 2008 .

[30]  Naír Rodríguez-Hornedo,et al.  Analysis of 50 Crystal Structures Containing Carbamazepine Using the Materials Module of Mercury CSD , 2009 .

[31]  Margaret C. Etter,et al.  Hydrogen bonds as design elements in organic chemistry , 1991 .

[32]  M. Berthelot,et al.  HYDROGEN-BOND BASICITY PKHB SCALE OF SIX-MEMBERED AROMATIC N-HETEROCYCLES , 1998 .

[33]  C. Hunter,et al.  Quantifying intermolecular interactions: guidelines for the molecular recognition toolbox. , 2004, Angewandte Chemie.

[34]  William Jones,et al.  Pharmaceutical Cocrystallization: Engineering a Remedy for Caffeine Hydration , 2005 .

[35]  David R. Weyna,et al.  Hierarchy of supramolecular synthons: persistent hydroxyl...pyridine hydrogen bonds in cocrystals that contain a cyano acceptor. , 2007, Molecular pharmaceutics.

[36]  Andrew V. Trask,et al.  An overview of pharmaceutical cocrystals as intellectual property. , 2007, Molecular pharmaceutics.

[37]  N. Rodríguez-Hornedo,et al.  Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine , 2008 .